A phase I-II study of bi-weekly gemcitabine and irinotecan as second-line chemotherapy in non-small cell lung cancer after prior taxane + platinum-based regimens.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples